Medallion Wealth Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50
Closed -$194 1284
2026
Q1
$194 Hold
50
﹤0.01% 1099
2025
Q4
$209 Hold
50
﹤0.01% 1094
2025
Q3
$165 Hold
50
﹤0.01% 1082
2025
Q2
$71 Hold
50
﹤0.01% 1082
2025
Q1
$75 Hold
50
﹤0.01% 1057
2024
Q4
$75 Buy
+50
New +$43 ﹤0.01% 1000

Other funds holding PGEN

Medallion Wealth Advisors's PGEN Position: Q2 2026 in Review

Medallion Wealth Advisors sold out of Precigen (PGEN) in Q2 2026, closing a stake of 50 shares — an estimated $194 sold.

Medallion Wealth Advisors first reported a position in PGEN in Q4 2024 and held it in 6 quarters. The position peaked at $209 in Q4 2025. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Medallion Wealth Advisors reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Medallion Wealth Advisors sold 50 Precigen shares in Q2 2026, an estimated $194.
  • Medallion Wealth Advisors first reported a position in Precigen in Q4 2024 and held it in 6 quarters.
  • Medallion Wealth Advisors's Precigen position peaked at $209 in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.